197 related articles for article (PubMed ID: 37848344)
1. Efficacy and safety of probiotic-supplemented bismuth quadruple therapy for the treatment of
Yao G; Fan X; Lu D
J Int Med Res; 2023 Oct; 51(10):3000605231203841. PubMed ID: 37848344
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of Probiotic Supplementation Therapy for Helicobacter pylori Eradication: A Meta-Analysis of Randomized Controlled Trials.
Lü M; Yu S; Deng J; Yan Q; Yang C; Xia G; Zhou X
PLoS One; 2016; 11(10):e0163743. PubMed ID: 27723762
[TBL] [Abstract][Full Text] [Related]
3. The "three-in-one" formulation of bismuth quadruple therapy for Helicobacter pylori eradication with or without probiotics supplementation: Efficacy and safety in daily clinical practice.
Zagari RM; Romiti A; Ierardi E; Gravina AG; Panarese A; Grande G; Savarino E; Maconi G; Stasi E; Eusebi LH; Farinati F; Conigliaro R; Bazzoli F; Romano M
Helicobacter; 2018 Aug; 23(4):e12502. PubMed ID: 29924430
[TBL] [Abstract][Full Text] [Related]
4. High-dose dual therapy versus bismuth-containing quadruple therapy for the treatment of
Zhang C; Zhang J; Cheng YJ
Saudi J Gastroenterol; 2023; 29(2):88-94. PubMed ID: 36960527
[TBL] [Abstract][Full Text] [Related]
5. Vonoprazan-amoxicillin dual therapy versus bismuth-containing quadruple therapy for Helicobacter pylori eradication: A systematic review and meta-analysis.
Zhou BG; Jiang X; Ding YB; She Q; Li YY
Helicobacter; 2024; 29(1):e13040. PubMed ID: 37983865
[TBL] [Abstract][Full Text] [Related]
6. High dose dual therapy versus bismuth quadruple therapy for Helicobacter pylori eradication treatment: A systematic review and meta-analysis.
Yang X; Wang JX; Han SX; Gao CP
Medicine (Baltimore); 2019 Feb; 98(7):e14396. PubMed ID: 30762742
[TBL] [Abstract][Full Text] [Related]
7. High Effective of 14-Day High-Dose PPI- Bismuth-Containing Quadruple Therapy with Probiotics Supplement for Helicobacter Pylori Eradication: A Double Blinded-Randomized Placebo-Controlled Study.
Poonyam P; Chotivitayatarakorn P; Vilaichone RK
Asian Pac J Cancer Prev; 2019 Sep; 20(9):2859-2864. PubMed ID: 31554388
[TBL] [Abstract][Full Text] [Related]
8. Meta-analysis of the efficacy of probiotics in Helicobacter pylori eradication therapy.
Zhu R; Chen K; Zheng YY; Zhang HW; Wang JS; Xia YJ; Dai WQ; Wang F; Shen M; Cheng P; Zhang Y; Wang CF; Yang J; Li JJ; Lu J; Zhou YQ; Guo CY
World J Gastroenterol; 2014 Dec; 20(47):18013-21. PubMed ID: 25548501
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of Lactobacillus-supplemented triple therapy for Helicobacter pylori infection in children: a meta-analysis of randomized controlled trials.
Fang HR; Zhang GQ; Cheng JY; Li ZY
Eur J Pediatr; 2019 Jan; 178(1):7-16. PubMed ID: 30446816
[TBL] [Abstract][Full Text] [Related]
10. The effect of supplementing with
Chen Y; Teng T; Su Y; Chen WZ
Front Med (Lausanne); 2024; 11():1344702. PubMed ID: 38695028
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of probiotics in eradicating Helicobacter pylori: A network meta-analysis.
Shi X; Zhang J; Mo L; Shi J; Qin M; Huang X
Medicine (Baltimore); 2019 Apr; 98(15):e15180. PubMed ID: 30985706
[TBL] [Abstract][Full Text] [Related]
12. [Influence of different timing of
He CX; Kong FT; Liang F; Wang KX; Li H; Liu YL; Zhao W; Zhou PP; Kong FL
Zhonghua Yi Xue Za Zhi; 2019 Jun; 99(22):1731-1734. PubMed ID: 31216821
[No Abstract] [Full Text] [Related]
13. Efficacy and safety of bismuth-containing quadruple treatment and concomitant treatment for first-line Helicobacter pylori eradication: A systematic review and meta-analysis.
Guo B; Cao NW; Zhou HY; Chu XJ; Li BZ
Microb Pathog; 2021 Mar; 152():104661. PubMed ID: 33249167
[TBL] [Abstract][Full Text] [Related]
14. [A meta-analysis of randomized controlled trials of bismuth-containing quadruple therapy combined with probiotic supplement for eradication of
Si XB; Lan Y; Qiao L
Zhonghua Nei Ke Za Zhi; 2017 Oct; 56(10):752-759. PubMed ID: 29036957
[No Abstract] [Full Text] [Related]
15. The cure rate of 10-day bismuth-containing quadruple therapy for Helicobacter pylori eradication is equivalent to 14-day: a systematic review and meta-analysis.
Ding YM; Li YY; Liu J; Wang J; Wan M; Lin MJ; Lin BS; Zhang WL; Kong QZ; Wang ST; Mu YJ; Duan M; Han ZX; Zuo XL; Li YQ
Clin Exp Med; 2023 Aug; 23(4):1033-1043. PubMed ID: 36538198
[TBL] [Abstract][Full Text] [Related]
16. The effect of Saccharomyces boulardii supplementation on Helicobacter pylori eradication in children: a systematic review and meta-analysis of Randomized controlled trials.
Liu LH; Han B; Tao J; Zhang K; Wang XK; Wang WY
BMC Infect Dis; 2023 Dec; 23(1):878. PubMed ID: 38102568
[TBL] [Abstract][Full Text] [Related]
17. Optimum duration of regimens for Helicobacter pylori eradication.
Yuan Y; Ford AC; Khan KJ; Gisbert JP; Forman D; Leontiadis GI; Tse F; Calvet X; Fallone C; Fischbach L; Oderda G; Bazzoli F; Moayyedi P
Cochrane Database Syst Rev; 2013 Dec; (12):CD008337. PubMed ID: 24338763
[TBL] [Abstract][Full Text] [Related]
18. High-Dose Dual Therapy Versus Bismuth-Containing Quadruple Therapy for the Treatment of Helicobacter pylori Infection: A Systematic Review with Meta-Analysis.
Yin Z; Li J; Huang W; Lei X; Xu D; Xu G; Li H; Zhang J
Turk J Gastroenterol; 2022 Jun; 33(6):454-462. PubMed ID: 35786612
[TBL] [Abstract][Full Text] [Related]
19. Comparison of 10 and 14 days of antofloxacin-based versus 14 days of clarithromycin-based bismuth quadruple therapy for Helicobacter pylori eradication: A randomized trial.
He XJ; Wang XL; Huang XY; Li DZ; Liu G; Wang W; Li DL
Clin Res Hepatol Gastroenterol; 2023 Jan; 47(1):102052. PubMed ID: 36400418
[TBL] [Abstract][Full Text] [Related]
20. Third-line and rescue therapy for refractory
de Moraes Andrade PV; Monteiro YM; Chehter EZ
World J Gastroenterol; 2023 Jan; 29(2):390-409. PubMed ID: 36687120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
